Non-Hormonal Contraceptives Market - By Type, By Gender, By Age Group - Global Forecast, 2025 - 2034

Non-Hormonal Contraceptives Market Size

The global non-hormonal contraceptives market size was valued at USD 19.9 billion in 2024. The market is expected to reach from USD 21.3 billion in 2025 to USD 39.1 billion in 2034, growing at a CAGR of 7% during the forecast period. Rising awareness among people for protective sexual activities, favorable government initiatives, coupled with growing preference for hormone-free contraceptives is anticipated to propel the market growth over the forecast period.
 

Increase in preference for easy contraceptual methods such as condoms is expected to fuel the market growth positively. For instance, as per the reported data by Union Health Ministry of India, there were around 337 million units of condoms sold in 2021-22 in India. There was a rise of around 7% compared to previous year. Significant percentage of males especially from the developing countries tend to use condoms as they offer prevention from different sexually transmitted diseases (STDs), pocket-friendly and are easily available through various distribution modes.
 

Additionally, growing preference of people towards non-hormonal methods of birth control is a key factor propelling the product demand. This is primarily attributed to some of the common side effects associated with hormonal contraceptives such as mood swings, weight gain, etc. Users who are more prone to hormonal products prefer or are shifting towards the potential alternatives, thereby, boosting the market growth.
 

Moreover, availability of key non-hormonal products through established distribution modes is contributing to increased product demand. Online channels, retail pharmacy chains and local convenience stores offer users easy and affordable product availability. Thus, the afore-mentioned parameters are anticipated to fuel the industry growth over the projected timeframe.
 

Non-hormonal contraceptives prevent pregnancy without using products with synthetic hormones. Some of the key non-hormonal birth control methods include male or females sterilization coupled with use of various other devices such as intrauterine devices, condoms, etc.
 

Non-Hormonal Contraceptives Market Trends

• Growing adoption of e-commerce platforms, supportive government initiatives, rise in number of female workforce, and technological advancements in products are among the key trends supporting the market growth.
   
• Women are an integral part of the global workforce. The percentage of women in overall workforce is increasing, necessitating them to use proper birth control methods throughout their working span. For instance, according to statistics reported by the U.S. Chamber of Commerce and U.S. Bureau of Labor Statistics, around 47% of the total U.S. workforce are women. Thus, such high percentage of female employees make it necessary to opt for some form of contraceptives, thereby driving the market growth.
   
• High adoption rate of E-commerce platforms for ordering preferred non-hormonal products is further supporting the industry growth. The online websites offer range of benefits for their users including attractive discounts for first-time or daily users, free-home delivery of products along with the ability to order them at user convenience.
   
• Additionally, increasing demand for long-acting reversible contraception (LARC) is another key trend boosting the industry growth. These products enable the user to prevent the pregnancy for a period of around 8-10 years, offering a long-term solution.
   
• Moreover, favorable government schemes and policies aimed at improving the awareness levels along with conducting educational campaigns is anticipated to further increase the product demand over the forecast period.
   

Non-Hormonal Contraceptives Market Analysis

Based on type, the market is bifurcated into devices, sterilization, and other product types. The devices segment is expected to expand at a CAGR of 7.2%, reaching around USD 29.4 billion by 2034. The global market was valued at around USD 18.6 billion in 2023.
 

• Non-hormonal devices such as IUDs, vaginal rings, condoms, and subdermal implants are among the key products used for birth control. Copper intrauterine devices are used by a substantial percentage of women as the preferred method of contraception worldwide. For instance, as per the published data by United Nations Development Programme, around 21.5% of women use IUDs as a contraceptive method in France.
   
• Condom is also among the key products that offer both birth control measures and prevention from sexually transmitted diseases. For instance, according to a data published in a report by World Health Organization (WHO), an estimated 117 million new HIV infections were prevented in 77 countries with a high AIDS prevalence since 1990. This high number highlights the importance of using condoms, thereby aiding product demand.
   
• Other devices such as vaginal rings, diaphragm, subdermal implants, etc. also offer significant prevention from birth control. Users seeking for hormone-free contraception other than IUDS and condoms prefer such products, resulting in overall market growth.
   

Based on gender, the non-hormonal contraceptives market is classified into male and female. The female segment accounted for majority revenue share and was valued at USD 12.6 billion in 2024.
 

• Demand for different non-hormonal contraceptives by women include use of long-acting reversible contraceptives (LARCs), subdermal implants, various spermicidal creams and gels along with tubectomy.
   
• Women choose the preferred method based on factors such as personal preferences, products offering a combination of effective birth control and health considerations along with broader societal trends.
   
• Tubectomy or tubal ligation is among a key method for permanent pregnancy prevention in females. Women above the age group of 40 and who are near the menopause tends to prefer this method as they want a long-term and hassle-free solution for pregnancy prevention. Tubal ligation is a surgical procedure that involves closing or tying the fallopian tubes for permanent sterilization.
   
• Further, growing awareness, rise in disposable income and increase in overall women workforce are other parameters propelling the market growth.

Based on age group, the non-hormonal contraceptives market is segmented into 15-44 years and above 44 years. The above 44 years segment dominated the market in 2024 with a share of 54.3% and is anticipated to reach USD 20.8 billion by 2034.
 

• Women in this age group may have multiple ongoing health complications such as hypertension, risks of cardiovascular events, etc. to avoid further complications, they prefer non-hormonal contraceptives such as copper IUDs, vaginal creams and gels, or tubal ligation among others.
   
• In addition, women in this age category often needs long-term solution for prevention of pregnancies as they are nearing their menopause and don't want any unavoidable episode in terms of pregnancies.
   
• Further, use of male contraceptive methods such as vasectomy and condoms are among the most preferred methods for males in this age group. Permanent male sterilization or vasectomy is generally a recommended method for males in this age category owing to their health issues among other reasons. Thus, above-mentioned parameters are anticipated to fuel the segmental progression over the projected timeframe.

U.S. non-hormonal contraceptives market accounted for USD 5.8 billion in 2024. The U.S. dominated the North American market in 2023 with USD 5.5 billion growing from USD 5.2 billion in 2022 and is anticipated to grow at a CAGR of 5.2% between 2025 to 2034 period.
 

• People suffering from various health conditions including hormonal disorders such as thyroid and polycystic ovary syndrome are among the primary users of non-hormonal contraceptives.
   
• In addition, the non-hormonal contraceptive products have witnessed increased growth owing to cultural and political policies that prevent abortion in some of the U.S. states.
   
• Further, use of advance and minimally invasive sterilization techniques in permanent male and female sterilization procedures is encouraging users, as they are relatively painless.
   
• Increase in focus of industry players towards advance research for male contraception products such as injectable hydrogels are anticipated to prove beneficial and increase product demand.
   

UK non-hormonal contraceptives market in the Europe is projected to grow remarkably in the coming years.
 

• Use of male and female condoms is an important method of contraception preferred by younger population in the country. The easy availability and affordability of condoms make them a go-to product for birth control measures.
   
• Advancement in condoms such as presence of biodegradable and ultra-thin condoms is further expected to fuel the product demand.
   
• Additionally, owing to higher percentage of women in overall workforce that needs planned and delayed pregnancies, is projected to boost the demand for non-hormonal contraceptives in the country.
   
• Moreover, according to the data reported by United Nations Development Programme, around 9% of the women use intrauterine devices in UK preferring long-term solutions for birth control.
   

India holds a key position in the Asia Pacific non-hormonal contraceptives market.
 

• Women empowerment leading to rise in female workforce is a key growth parameter fueling the Indian contraceptives market. For instance, according to the data published in the Periodic Labour Force Survey Report 2022-23 released by the Ministry of Statistics and Programme Implementation, the percentage of women workforce reached 37% in 2023. It registered a rise of around 4.2% percentage in comparison to 2021-22 numbers.
   
• Further, dual advantages offered by condoms such as prevention from both unwanted pregnancies and sexually transmitted diseases is among a key factor promoting the segmental growth in the country.
   

The Brazil non-hormonal contraceptives market is experiencing robust growth in Latin American market.
 

• Increasing urbanization, presence of large number of sexually active people, rising awareness coupled with supportive government initiatives are anticipated to propel the market growth.
   
• The Brazilian government is working on promoting sexual awareness through educational campaigns and health programs. It also offers subsidized or free contraceptives such as condoms to the country's citizens.
   
• Further, evolving societal trends along with other parameters such as planned delayed pregnancies and side-effects of hormonal contraceptives is resulting in considerable market growth and is anticipated to record robust growth over the forecast period.
   

Non-Hormonal Contraceptives Market Share

The major players in the market focus on product innovation related to materials, novel contraceptives, etc. Leading industry players accounts for around 40% share in the global market. Also, they have a keen focus on product expansion, improving distribution lines, and geographical expansion in untapped markets. Companies such as Bayer, Reckitt, and Church & Dwight aims at offering a range of options to the users such as copper IUDs, condoms, and spermicidal products. Strategic collaborations with healthcare providers and government programs further support their market presence.
 

Non-Hormonal Contraceptives Market Companies

Prominent players operating in the non-hormonal contraceptives industry include:

• abbVie
• Bayer
• Church & Dwight Co.
• CooperCompanies
• CUPID
• FUJI LATEX
• HLL Lifecare
• Mankind
• MAYER
• VIATRIS
• Okamoto
• PREGNA INTERNATIONAL
• reckitt
• SMB
• veru
   

USPs:

• Reckitt focuses on expanding the industry presence of its leading industry brand in male condoms 'Durex'. The company has launched multiple innovative and technologically advance products across various geographies. Innovation in the materials used in condoms is among the key focus area for the company.
   
• Bayer leverages its expertise in women focused product line, prioritizing innovation in its long-acting reversible contraceptives (LARCs) like copper IUDs. The company also invest in digital marketing and collaboration with healthcare providers to foster growth.
   

Non-Hormonal Contraceptives Industry News:

• In September 2024, Durex, a brand of Reckitt, launched its 'Close-Fit Thin Condoms' in India. It is a segment's first in the country and the brand is promoting it as invisible condoms. Such innovative product launch may enable the company to further consolidate its leading industry position in the country.
   
• In April 2023, Veru Inc. announced a strategic partnership with Afaxys Group Services, LLC for the commercialization and distribution of Veru’s FC2 Female Condom through AGS Group Purchasing Organization (GPO). This strategic move helped the company to expand into new geographical locations and improve its sales prospect.
   
• In December 2022, CooperSurgical, Inc. announced a strategic partnership with Ostro to launch a new consumer engagement solution for its hormone-free IUD, Paragard.
   

The non-hormonal contraceptives market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Devices
  • Condoms
    • Male
    • Female
  • Intra-uterine devices
  • Vaginal rings
  • Subdermal implants
  • Other devices 
• Sterilization
  • Vasectomy
    • No-scalpel vasectomy
    • Conventional vasectomy
    • Minimally invasive vasectomy
  • Tubal ligation
    • Laparoscopic tubal ligation
    • Hysteroscopic tubal ligation
    • Mini-Laparotomy
    • Other procedures
• Other product types

Market, By Gender

• Male
• Female

Market, By Age Group

• 15-44 years
• Above 44 years

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE